Australia: Mallinckrodt Hospital Products IP Receives Patent for 'Cannula For Minimizing Dilution of Dosing during Nitric Oxide Delivery'

Australia, May 3 -- Mallinckrodt Hospital Products IP Ltd., Ireland, has filed an application (2022200646) on Feb. 1, 2022, for 'Cannula For Minimizing Dilution of Dosing during Nitric Oxide Delivery.'

The patent is effective from Dec. 4, 2013, till Dec. 4, 2033.

Inventor(s): Craig Flanagan, Simon Freed, John Klaus, Thomas Kohlmann, Martin D. Meglasson, Manesh Naidu and S.A Parag

Application Status: Accepted

Acceptance Date: April 15

Paid to Date: Dec. 4

The original document can be viewed at: http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do?applicationNo=2022200646

Disclaimer: Curated by HT Syndication....